Pilot Study of Internet-based Cognitive Behavior Therapy for Fibromyalgia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01468961 |
Recruitment Status
:
Completed
First Posted
: November 10, 2011
Last Update Posted
: August 22, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Fibromyalgia | Behavioral: Internet-based CBT | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 41 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Pilot Study of Internet-based Cognitive Behavior Therapy for Fibromyalgia |
Study Start Date : | November 2011 |
Actual Primary Completion Date : | September 2012 |
Actual Study Completion Date : | September 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: Internet-based CBT |
Behavioral: Internet-based CBT
10 weeks of internet-based CBT with online therapist contact
|
- The Fibromyalgia Impact Questionnaire [ Time Frame: Once, 1 week before start of treatment ]
- The Fibromyalgia Impact Questionnaire [ Time Frame: Once, immediately after treatment ]
- The Fibromyalgia Impact Questionnaire [ Time Frame: Once, 6 months after treatment ]
- Short form 12-item Questionnaire [ Time Frame: Once, 1 week before start of treatment ]
- Short form 12-item Questionnaire [ Time Frame: Once, immediately after treatment ]
- Short form 12-item Questionnaire [ Time Frame: Once, 6 months after treatment ]
- Hospital Anxiety and Depression Scale [ Time Frame: Once, 1 week before start of treatment ]
- Hospital Anxiety and Depression Scale [ Time Frame: Once, immediately after treatment ]
- Hospital Anxiety and Depression Scale [ Time Frame: Once, 6 months after treatment ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Current diagnosis of fibromyalgia
Exclusion Criteria:
- Current diagnosis of severe psychiatric disorder

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01468961
Sweden | |
Karolinska Institutet, Department of Clinical Neuroscience, Section of psychiatry, Karolinska Hospital Solna R5 | |
Stockholm, Sweden, 171 76 |
Publications of Results:
Responsible Party: | Brjann Ljotsson, Associate professor, Karolinska Institutet |
ClinicalTrials.gov Identifier: | NCT01468961 History of Changes |
Other Study ID Numbers: |
FIBRO-P |
First Posted: | November 10, 2011 Key Record Dates |
Last Update Posted: | August 22, 2017 |
Last Verified: | August 2017 |
Additional relevant MeSH terms:
Fibromyalgia Myofascial Pain Syndromes Muscular Diseases Musculoskeletal Diseases |
Rheumatic Diseases Neuromuscular Diseases Nervous System Diseases |